ELV

Elevance Health

ELV · Salud · Next earnings: 21 Oct 2026 · Before the open · Q3 2026

Relevance 41/100 · Minor

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.

Sector Healthcare · Healthcare Plans
Website https://www.elevancehealth.com

What the market expects

ConsensusPrior-year EPS

EPS4.696.03

Revenue49,164,023,370—

19 analysts

How expectations have moved

Expectations: Neutral

Expectativas neutrales: cotiza a un 7% de su máximo de 52 semanas.

Stock, 90 days: -3.8%

Prior behaviour

Average absolute move: 3.9%
Largest move: 8.5%
releases with a move larger than 5%: 50%
beat the EPS consensus in: 4 of the last 4

Quarter Date 1-session move Surprise EPS

Jun 2026 15 Jul 2026 -8.5% +20.6%

Mar 2026 22 Apr 2026 +0.0% +17.8%

Dec 2025 28 Jan 2026 +5.9% +7.4%

Sep 2025 21 Oct 2025 -1.2% +21.1%

Historical moves describe typical magnitude, not a future direction.

Expected move

±3.9% (historical)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price: 404.31
30 days: -0.8%
90 days: -3.8%
Distance to 52-week high: -7.3%
Market cap: 86,767,231,000

Metrics to watch

El trimestre anterior batió el consenso de BPA un 21%.
Ventas del fármaco o producto principal
Guidance de ingresos anual
Avances de pipeline / ensayos clínicos mencionados
Margen operativo
BPA e ingresos frente al consenso (sorpresa)
Cambio en el guidance respecto al trimestre anterior
Reacción del mercado frente al movimiento histórico y al implícito

Relevance breakdown

market_cap: 11.3
analyst_coverage: 7.6
estimate_revisions: 0.5
recent_price_move: 0.3
historical_earnings_vol: 5.9
sector_importance: 4.0
recent_news_coverage: 7.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.